Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WHIO-TV 7 Dayton· 5 days agoWASHINGTON — (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
Here Are the Fastest Ways to Save on Your Prescription Drugs
The Motley Fool· 6 hours agoIf prescription drug prices are straining your personal finances, your insurance coverage might be...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 5 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 5 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
ABC News· 5 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Walgreens inks GLP-1 clinical trial deal with major German drugmaker
Healthcare Dive via Yahoo Finance· 2 days agoUnder the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
NBC New York· 6 days agoA federal judge in New Jersey rejected Johnson & Johnson and Bristol Myers Squibb's legal challenges...
Mendez: Price caps on inhalers won’t do enough
Boston Herald· 2 days agoPresident Biden recently held an event to celebrate that three major drugmakers announced they are putting a $35 monthly out-of-pocket price cap on...
Eli Lilly Just Announced More Good News: Time to Buy?
Motley Fool via Yahoo Finance· 7 days agoThe pharmaceutical business is a tricky one. Developing novel therapies costs hundreds of thousands...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...